Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5599542 | Atherosclerosis | 2017 | 24 Pages |
Abstract
The study showed that PHLA60 identifies a subgroup of MCM with a defect in lipolysability and/or hepatic clearance of triglycerides-rich lipoproteins, and a larger one with a defect in LPL availability. These findings provide new insights into the heterogeneity of MCM and might contribute to adjust treatment targeting.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Oriane Marmontel, Mathilde Di Filippo, Christophe Marcais, Séverine Nony, Marjorie Dumoux, Marine Serveaux-Dancer, Cyrielle Caussy, Sybil Charrière, Philippe Moulin,